Horizon Pharmaceutical Inactive 10-Q2002 Q3 Quarterly report

Filed: 14 Nov 02, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: ability, adversely, annexed, Aquilar, assay, assigned, Assignment, Australian, authorized, behalf, board, carcinogenicity, committee, concluded, consulting, data, David, default, defined, disclosed, Dr, duly, ensure, equivalent, evaluated, evaluation, fact, final, formulated, fraud, function, gain, Greig, guidance, Henry, inhibition, involved, isomer, jointly, knowledge, light, longer, mechanism, method, Nigel, notified, performing, Posiphen, precursor, principal, protein, provisional, rapid, recent, responsible, return, reviewed, RNA, role, screening, significantly, Small, spending, state, statement, Subasinghe, summarize, Supundi, thereunto, translational, treating, undersigned, untrue, vesting

Removed: approximately, case, check, committed, Employer, equally, existing, Identification, mark, offset, outlined, outstanding, past, preceding, professional, shorter, TRANSITION, Washington

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Horizon Pharmaceutical similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 99.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Axonyx Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2002 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Marvin S. Hausman, M.D., President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Marvin S. Hausman, M.D.
Marvin S. Hausman, M.D.
President and Chief Executive Officer
November 13, 2002

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.